Keywords : Xenograft, Allograft
Although breast repair may be necessary because of trauma and congenital defects, a driving force for repair procedures is breast cancer. The incidence of new cancers inEuropeis increasing at a minimal pace as of 2011, in part due to a maturation of screening protocols and public awareness. Included in this report is a summary of the procedures performed inGermany,France,U.K.,Italy,Spain, theNetherlands,Sweden,Denmark,AustriaandSwitzerland. Ra...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Although breast repair may be necessary because of trauma and congenital defects, a driving force for repair procedures is breast cancer. The incidence of new cancers inEuropeis increasing at a minimal pace as of 2011, in part due to a maturation of screening protocols and public awareness. Included in this report is a summary of the procedures performed inGermany,France,U.K.,Italy,Spain, theNetherlands,Sweden,Denmark,AustriaandSwitzerland.
Rates of breast reconstruction inEuropeare low relative to the potential number of women who could benefit from such surgeries. In general, women who opt for reconstruction surgery tend to be younger, well educated, possess higher levels of employment, and are more sexually active than those who chose to live without reconstruction after cancer treatment. Utilization is driven by the public healthcare systems of Europe and, as studied in the Nordic countries such asSweden, in countries where public funding is available, the proportion of patients who are married is also higher.
Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for Germany, France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Segments Included:
Breast Tissue Repair
Breast Reconstruction
Breast Augmention
Companies Included:
LifeCell
Covidien
TEI Biosciences Inc.
PFM Medical
Ethicon
Biomerix Corporation
Novus Scientific
CR Bard
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
Surgical Equipment Industry in Europe
EXECUTIVE SUMMARY. 1
1.1 U.S.MARKET FOR SOFT TISSUE REPAIR 1
1.2 BREAST RECONSTRUCTION REPAIR MARKET 2
1.3 DURAL REPAIR MARKET 3
1.4 VAGINAL SLING MARKET. 4
1.5 SKIN REPAIR MARKET 5
1.6 SPORTS MEDICINE AND TENDON REPAIR MARKET 6
1.7 DENTAL MEMBRANE MARKET. 7
1.8 COMPETITIVE ANALYSIS 8
RESEARCH METHODOLOGY. 9
2.1 RESEARCH SCOPE . 9
2.2 IDATA’S 9-STEP METHODOLOGY . 9
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research. 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research. 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis . 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release . 20
Step 9: Customer Feedback and Market Monitoring. 21
U.S. SOFT TISSUE REPAIR MARKET OVERVIEW. 22
3.1 INTRODUCTION . 22
3.2MARKET OVERVIEW. 24
3.3 TREND ANALYSIS BY SEGMENT. 29
3.4MARKET DRIVERS AND LIMITERS 32
3.4.1 Market Drivers 32
3.4.2 Market Limiters. 33
3.5 COMPETITIVE ANALYSIS 37
3.5.1 Market Concentration. 48
3.6MERGERS AND ACQUISITIONS 50
BREAST RECONSTRUCTION MARKET. 52
4.1 INTRODUCTION . 52
4.2MARKET OVERVIEW. 53
4.3MARKET ANALYSIS AND FORECAST 58
4.3.1 Allograft Market . 61
4.3.2 Synthetic Mesh Market 64
4.3.3 Xenograft Market 67
4.4MARKET DRIVERS AND LIMITERS 70
4.4.1 Market Drivers 70
4.4.2 Market Limiters. 70
4.5 COMPETITIVE ANALYSIS 72
HERNIA REPAIR MARKET 77
5.1 INTRODUCTION . 77
5.2MARKET OVERVIEW. 78
5.3MARKET ANALYSIS AND FORECAST 83
5.3.1 Allograft Market . 86
5.3.2 Xenograft Market 89
5.3.3 Synthetic Mesh Market 92
5.4MARKET DRIVERS AND LIMITERS 95
5.4.1 Market Drivers 95
5.4.2 Market Limiters. 96
5.5 COMPETITIVE ANALYSIS 97
DURAL REPAIR MARKET 103
6.1 INTRODUCTION . 103
6.2MARKET OVERVIEW. 104
6.3MARKET ANALYSIS AND FORECAST 109
6.3.1 Allograft Market . 112
6.3.2 Xenograft Market 115
6.3.3 Synthetic Material Market 118
6.4MARKET DRIVERS AND LIMITERS 121
6.4.1 Market Drivers 121
6.4.2 Market Limiters. 121
6.5 COMPETITIVE ANALYSIS 123
VAGINAL SLING MARKET 129
7.1 INTRODUCTION . 129
7.2MARKET OVERVIEW. 130
7.3MARKET ANALYSIS AND FORECAST 135
7.3.1 Synthetic Market . 138
7.3.2 Non-Synthetic Market . 141
7.4MARKET DRIVERS AND LIMITERS 144
7.4.1 Market Drivers 144
7.4.2 Market Limiters. 145
7.5 COMPETITIVE ANALYSIS 146
SKIN REPAIR MARKET 149
8.1 INTRODUCTION . 149
8.2MARKET OVERVIEW. 150
8.3MARKET ANALYSIS AND FORECAST 155
8.3.1 Allogenic Material Market 158
8.3.2 Biosynthetic Material Market . 161
8.4MARKET DRIVERS AND LIMITERS 164
8.4.1 Market Drivers 164
8.4.2 Market Limiters. 165
8.5 COMPETITIVE ANALYSIS 166
SPORTS MEDICINE AND TENDON REPAIR MARKET. 171
9.1 INTRODUCTION . 171
9.2MARKET OVERVIEW. 172
9.3MARKET ANALYSIS AND FORECAST 177
9.3.1 Shoulder Repair Market 180
9.3.1.1 Shoulder Repair Allograft Market .183
9.3.1.2 Shoulder Repair Xenograft Market .186
9.3.1.3 Shoulder Repair Synthetic Market.189
9.3.2 Achilles Tendon Repair Market 192
9.3.2.1 Achilles Tendon Repair Allograft Market195
9.3.2.2 Achilles Tendon Repair Xenograft Market 198
9.3.2.3 Achilles Tendon Repair Synthetic Market .201
9.4MARKET DRIVERS AND LIMITERS 204
9.4.1 Market Drivers 204
9.4.2 Market Limiters. 205
9.5 COMPETITIVE ANALYSIS 206
DENTAL MEMBRANE MARKET 210
10.1 INTRODUCTION . 210
10.2MARKET OVERVIEW. 211
10.3MARKET ANALYSIS AND FORECAST 216
10.3.1 Acellular Dermal Matrix Market 219
10.3.2 Xenograft Market 222
10.3.3 Alloplast/Synthetic Market 225
10.4MARKET DRIVERS AND LIMITERS 228
10.4.1 Market Drivers 228
10.4.2 Market Limiters. 228
10.5 COMPETITIVE ANALYSIS 230
ABBREVIATIONS 234
